Company
L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
MATERIOMICS makes pharma, drug development and toxicology faster, more reliable and more successful -replacing animal tests- with the revolutionary family of ACE organ tests models (liver, colon, heart) featuring our proprietary surface topographies
Maastricht, Maastricht, Netherlands
Send a message
Anglais
Anglais
MATERIOMICS is a VC backed biotech company located in The Netherlands. Surface structure, next to chemical composition, directs the interaction between (medical) devices and (human) cells. Based on this concept -cell behavior is guided by surface structure- MATERIOMICS designs algorithm-based unique surface topographies to improve the performance of cell culture ware and medical devices.
Using our proprietary TopoChip technology we identify the optimal designed surface topography to...
MATERIOMICS is a VC backed biotech company located in The Netherlands. Surface structure, next to chemical composition, directs the interaction between (medical) devices and (human) cells. Based on this concept -cell behavior is guided by surface structure- MATERIOMICS designs algorithm-based unique surface topographies to improve the performance of cell culture ware and medical devices.
Using our proprietary TopoChip technology we identify the optimal designed surface topography to functionalize cell culture ware and improve the condition, quality and quantity of cells cultured in vitro (in the lab). The revolutionary family of ACE products significantly enhance organ test model performance and make pharma, drug development and toxicology faster, more reliable and more successful.
Our first ACE product is ACE/liver. The current gold standard allows human liver cells to be cultured for max. 8 days while loosing their typical behavior and functionality, requires complex coating conditions and is very limited in its use. In strong contrast, ACE/liver allows these cells to grow for a month, while remaining their typical behavior and functionality, and no coatings are needed. ACE products are in line with end-user pipelines as well as manufacturing processes.
Next to ACE, MATERIOMICS designs topographies to substantially augment medical implants including breast implants, catheters, orthopedic implants and biosensors. For every application MATERIOMICS has the best surface.
Start in 2009
2009
Founded by Prof. Clemens van Blitterswijk, Prof. Jan de Boer and Frank-Jan van der Velden, MBA.
2011
Co-owner and co-inventor Dr. Ir. Bernke Papenburg started working full-time for MATERIOMICS.
2011
1. Secured NGI pre-seed grant of €250k to progress the business case. 2. First commercial project.
2015
Secured VC Seed round of €1.4 million
2016-2017
1. EU-SME phase 1 grant: ACE business case development 2. Alira Health Wound Care Innovation Award
to be continued ...